US Personalized Medicine Market Research Report By Product Outlook (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), By Application Outlook (Oncology, CNS, Immunology, Respiratory, Others) and By End-User Outlook (Hospitals, Diagnostic Centers, Research Academic Institutes, Others)-Forecast to 2035

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. U.S. PERSONALIZED MEDICINE MARKET, BY PRODUCT OUTLOOK (USD BILLION)

6.1. Personalized Medicine Diagnostics

6.2. Personalized Medicine Therapeutics

6.3. Personalized Medical Care

6.4. Personalized Nutrition and Wellness

7. U.S. PERSONALIZED MEDICINE MARKET, BY APPLICATION OUTLOOK (USD BILLION)

7.1. Oncology

7.2. CNS

7.3. Immunology

7.4. Respiratory

7.5. Others

8. U.S. PERSONALIZED MEDICINE MARKET, BY END-USER OUTLOOK (USD BILLION)

8.1. Hospitals

8.2. Diagnostic Centers

8.3. Research Academic Institutes

8.4. Others

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market share Analysis

9.4. Major Growth Strategy in the Personalized Medicine Market

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Personalized Medicine Market

9.7. Key developments and growth strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales and Operating Income

9.8.2. Major Players RD Expenditure. 2023

10. COMPANY PROFILES

10.1. Roche

10.1.1. Financial Overview

10.1.2. Products Offered

10.1.3. Key Developments

10.1.4. SWOT Analysis

10.1.5. Key Strategies

10.2. Johnson and Johnson

10.2.1. Financial Overview

10.2.2. Products Offered

10.2.3. Key Developments

10.2.4. SWOT Analysis

10.2.5. Key Strategies

10.3. Amgen

10.3.1. Financial Overview

10.3.2. Products Offered

10.3.3. Key Developments

10.3.4. SWOT Analysis

10.3.5. Key Strategies

10.4. Gilead Sciences

10.4.1. Financial Overview

10.4.2. Products Offered

10.4.3. Key Developments

10.4.4. SWOT Analysis

10.4.5. Key Strategies

10.5. Novartis

10.5.1. Financial Overview

10.5.2. Products Offered

10.5.3. Key Developments

10.5.4. SWOT Analysis

10.5.5. Key Strategies

10.6. Merck

10.6.1. Financial Overview

10.6.2. Products Offered

10.6.3. Key Developments

10.6.4. SWOT Analysis

10.6.5. Key Strategies

10.7. Pfizer

10.7.1. Financial Overview

10.7.2. Products Offered

10.7.3. Key Developments

10.7.4. SWOT Analysis

10.7.5. Key Strategies

10.8. Biogen

10.8.1. Financial Overview

10.8.2. Products Offered

10.8.3. Key Developments

10.8.4. SWOT Analysis

10.8.5. Key Strategies

10.9. Guardant Health

10.9.1. Financial Overview

10.9.2. Products Offered

10.9.3. Key Developments

10.9.4. SWOT Analysis

10.9.5. Key Strategies

10.10. Thermo Fisher Scientific

10.10.1. Financial Overview

10.10.2. Products Offered

10.10.3. Key Developments

10.10.4. SWOT Analysis

10.10.5. Key Strategies

10.11. BristolMyers Squibb

10.11.1. Financial Overview

10.11.2. Products Offered

10.11.3. Key Developments

10.11.4. SWOT Analysis

10.11.5. Key Strategies

10.12. Exact Sciences

10.12.1. Financial Overview

10.12.2. Products Offered

10.12.3. Key Developments

10.12.4. SWOT Analysis

10.12.5. Key Strategies

10.13. Illumina

10.13.1. Financial Overview

10.13.2. Products Offered

10.13.3. Key Developments

10.13.4. SWOT Analysis

10.13.5. Key Strategies

10.14. Genentech

10.14.1. Financial Overview

10.14.2. Products Offered

10.14.3. Key Developments

10.14.4. SWOT Analysis

10.14.5. Key Strategies

10.15. AbbVie

10.15.1. Financial Overview

10.15.2. Products Offered

10.15.3. Key Developments

10.15.4. SWOT Analysis

10.15.5. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. U.S. PERSONALIZED MEDICINE MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT OUTLOOK, 2019-2035 (USD BILLIONS)

TABLE 3. U.S. PERSONALIZED MEDICINE MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION OUTLOOK, 2019-2035 (USD BILLIONS)

TABLE 4. U.S. PERSONALIZED MEDICINE MARKET SIZE ESTIMATES & FORECAST, BY END-USER OUTLOOK, 2019-2035 (USD BILLIONS)

TABLE 5. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 6. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. U.S. PERSONALIZED MEDICINE MARKET ANALYSIS BY PRODUCT OUTLOOK

FIGURE 3. U.S. PERSONALIZED MEDICINE MARKET ANALYSIS BY APPLICATION OUTLOOK

FIGURE 4. U.S. PERSONALIZED MEDICINE MARKET ANALYSIS BY END-USER OUTLOOK

FIGURE 5. KEY BUYING CRITERIA OF PERSONALIZED MEDICINE MARKET

FIGURE 6. RESEARCH PROCESS OF MRFR

FIGURE 7. DRO ANALYSIS OF PERSONALIZED MEDICINE MARKET

FIGURE 8. DRIVERS IMPACT ANALYSIS: PERSONALIZED MEDICINE MARKET

FIGURE 9. RESTRAINTS IMPACT ANALYSIS: PERSONALIZED MEDICINE MARKET

FIGURE 10. SUPPLY / VALUE CHAIN: PERSONALIZED MEDICINE MARKET

FIGURE 11. PERSONALIZED MEDICINE MARKET, BY PRODUCT OUTLOOK, 2024 (% SHARE)

FIGURE 12. PERSONALIZED MEDICINE MARKET, BY PRODUCT OUTLOOK, 2019 TO 2035 (USD Billions)

FIGURE 13. PERSONALIZED MEDICINE MARKET, BY APPLICATION OUTLOOK, 2024 (% SHARE)

FIGURE 14. PERSONALIZED MEDICINE MARKET, BY APPLICATION OUTLOOK, 2019 TO 2035 (USD Billions)

FIGURE 15. PERSONALIZED MEDICINE MARKET, BY END-USER OUTLOOK, 2024 (% SHARE)

FIGURE 16. PERSONALIZED MEDICINE MARKET, BY END-USER OUTLOOK, 2019 TO 2035 (USD Billions)

FIGURE 17. BENCHMARKING OF MAJOR COMPETITORS